Former Dendreon executive joins Onyx
SOUTH SAN FRANCISCO, Calif. — Onyx Pharmaceuticals has appointed a new SVP global corporate affairs.
John Osborn will be responsible for the public and government affairs activities of the company, as well as key stakeholder relationships, and will report to Onyx’s president and CEO N. Anthony Coles.
Prior to joining Onyx, Osborn previously served as EVP, general counsel and secretary at Dendreon.
FDA approves Lilly, BMS drug for KRAS wild-type colorectal cancer
NEW YORK — The Food and Drug Administration has approved a drug made by Eli Lilly and Bristol-Myers Squibb for treating a form of colorectal cancer, the two companies said.
Lilly and Bristol announced the approval of Erbitux (cetuximab) for treating colorectal cancer that is KRAS mutation-negative, expresses the epidermal growth factor receptor and has spread to other parts of the body, also known as metastasis. The drug is approved for use alongside a chemotherapy combination containing irinotecan, 5-fluorouracil and leucovorin, also known as FOLFIRI.
"Cancer is a heterogeneous disease, and we have learned that not all patients with mCRC should be viewed as the same," Bristol-Myers Squibb SVP global development and medical affairs Brian Daniels said. "Today’s approval demonstrates our ability to bring diverse cancer therapies to market that address the needs of patients with KRAS mutation-negative mCRC."
The drug already is approved for treating head and neck cancer.
PepsiCo, Theo Muller Group form joint venture, enter U.S. dairy market
PURCHASE, N.Y. — PepsiCo has established a joint venture with a privately held, Germany-based dairy business, through which the companies will enter the growing U.S. dairy market in mid-July with innovative premium yogurt products.
PepsiCo and Theo Muller Group said their joint venture, Muller Quaker Dairy, will launch the following yogurts:
Muller Corner and Muller Greek Corner offer a new way to enjoy yogurt with add-ins you can flip, stir or dip. Corner varieties include blueberry, strawberry, Crispy Crunch, Choco Balls, chocolate flakes and crunchy granola. The Greek-style varieties include honeyed apricot, strawberry, blackberry and raspberry, and caramelized almond;
Muller FrutUp varieties include Blueberry Bliss, Very Cherry, Luscious Lemon, Peach Passion Fruit, Radiant Raspberry and Splendid Strawberry, starting with fruit fresh from farmers and prepared onsite with the yogurt. The unique part is the fruit on top — perfect for scooping, swirling or mixing.
The lines will be sold through supermarket and club retailers in 17 markets in the Northeast and mid-Atlantic U.S. starting this summer.
As part of partnership, the companies are building a state-of-the-art yogurt manufacturing plant in Batavia, N.Y. Once completed in 2013, it will be one of the largest yogurt plants in the United States, and is expected to create more than 180 new jobs in upstate New York, PepsiCo and Theo Muller Group said.
"As we’ve seen through the success of our dairy business in other parts of the world, this is a category with strong growth prospects," said Mehmood Khan, PepsiCo chief scientific officer, global research and development. "Muller makes some of Europe’s most delicious and unique dairy products, and there is no better partner PepsiCo could have in order to meet historic U.S. consumer demand for premium yogurt. With the name recognition and trust Quaker provides, together, we will be able to offer U.S. consumers an amazing range of products that taste delicious and are unlike anything on the market currently."